1-Piperazineacetamide,2-(aminocarbonyl)-N- (4-amino-2,6-dichlorophenyl)-4-[5,5-bis(4- fluorophenyl)pentyl]-,(2S)- (138681-29-5)

Identification
Name:	1-Piperazineacetamide,2-(aminocarbonyl)-N- (4-amino-2,6-dichlorophenyl)-4-[5,5-bis(4- fluorophenyl)pentyl]-,(2S)-
Synonyms:	Draflazine;Draflazinum [INN-Latin];Draflazina [INN-Spanish];120770-34-5;1-[2-(4-amino-2,6-dichloroanilino)-2-oxoethyl]-4-[5,5-bis(4-fluorophenyl)pentyl]piperazine-2-carboxamide;1-Piperazineacetamide, 2-(aminocarbonyl)-N-(4-amino-2,6-dichlorophenyl)-4-(5,5-bis(4-fluorophenyl)pentyl)-,(+-)-;Draflazina;Draflazinum;Draflazine (USAN/INN);AC1L1U1V;AC1Q3MI7;Draflazine [USAN:BAN:INN];UNII-0Y25DT968Y;C30H33Cl2F2N5O2;CHEMBL1628717;LS-109873;D03906;R75231;R 75231;R 88016;R-75231;R-88016;R 75 231;R 88 016;( inverted exclamation markA)-4'-amino-4-(5,5-bis(p-fluorophenyl)pentyl)-2-carbamoyl-2',6'-dichloro-1-piperazineacetanilide;(+-)-4'-Amino-4-(5,5-bis(p-fluorophenyl)pentyl)-2-carbamoyl-2',6'-dichloro-1-piperazineacetanilide;1-Piperazineacetamide, 2-(aminocarbonyl)-N-(4-amino-2,6-dichlorophenyl)-4-(5,5-bis(4-fluorophenyl)pentyl)-;2-aminocarbonyl-N-(4-amino-2,6-dichlorophenyl)-4-(5,5-bis(4-fluorophenyl)-pentyl)-1-piperazineacetamide
CAS:	138681-29-5
Molecular Formula:	C₃₀H₃₃Cl₂F₂N₅O₂
Molecular Weight:	604.518126
InChI:	InChI=1S/C30H33Cl2F2N5O2/c31-25-15-23(35)16-26(32)29(25)37-28(40)18-39-14-13-38(17-27(39)30(36)41)12-2-1-3-24(19-4-8-21(33)9-5-19)20-6-10-22(34)11-7-20/h4-11,15-16,24,27H,1-3,12-14,17-18,35H2,(H2,36,41)(H,37,40)
Molecular Structure:
Properties
Flash Point:	411°C
Boiling Point:	755.9°Cat760mmHg
Density:	1.338g/cm3
Flash Point:	411°C
Safety Data

1-Piperazineacetamide,2-(aminocarbonyl)-N- (4-amino-2,6-dichlorophenyl)-4-[5,5-bis(4- fluorophenyl)pentyl]-,(2S)- (138681-29-5)

Other Product